Covexe
6.7#10 in systematic review softwareFrom $99 a yearFree planWeb
VisitCovexe vs RevMan
What both publish
| Fact | Covexe | RevMan |
|---|---|---|
| Headquarters | Taipei, Taiwan | London, United Kingdom |
| Intended users | Covexe says it is built for evidence-synthesis researchers and organizations including universities, research laboratories, public health institutes, hospitals, and independent researchers. | RevMan supports diagnostic test accuracy, intervention, methodology, overview, prognosis, qualitative, and flexible review types. |
| Maker | Covexe is built by Covexe Labs, described as an independent software team based in Taipei, Taiwan. | RevMan and Cochrane Interactive Learning are distributed and sold by The Cochrane Collaboration, a registered charity and company limited by guarantee in England and Wales. |
| Purpose | Covexe is a browser-based platform for systematic reviews, meta-analysis, evidence synthesis, and applied statistics. | RevMan is Cochrane’s software for producing transparent systematic reviews, guiding authors from structured data entry and analysis through result visualization. |
Covexe plans
- FreeFree
- Pro$99 a year
- Team$150 a year
- InstitutionPriced on request
RevMan plans
- Practice reviewFree
- Cochrane author accessFree
- Individual student annual subscription£80 a year
- Student£80 a year
- Academic£100 a year
- Individual academic annual subscription£100 a year
Pick Covexe if…
Covexe is intended for evidence-synthesis researchers and organizations such as universities, research laboratories, public health institutes, hospitals, and independent researchers. It may suit teams that need structured review workflows alongside statistical methods.
Pick RevMan if…
RevMan suits authors preparing systematic reviews across its listed review types, including people working collaboratively on analysis and writing. The free practice option may suit someone who can work within its deletion, export, and single-user limits.